Renal Denervation

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t respond to medication, suggests preliminary research presented at the 56th annual me...

Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 

SYMPLICITY HTN-3 TRial, ACC.14, renal denervation

A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy in the U.S. SYMPLICITY HTN-3 trial. This trial data was presented to a packed, standing-r...

renal denervation

One of the exciting new frontiers for interventional cardiology is the use of renal denervation therapy to treat pharmacologically uncontrolled hypertension. It is estimated there are more than 10 million drug-resistant hypertension patients...

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t...
June St. Jude Medical Inc. announced preliminary results from the EnligHTN III study, which found the company’s second-generation EnligHTN renal denervation...
Journal of Endovascular Therapy Hypertension Renal Denervation Therapy
Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 
Cardiosonic Inc CE mark TIVUS ablative catheter renal denervation hypertension
Cardiosonic Ltd. announced CE marking of its TIVUS (therapeutic intravascular ultrasound) ablative catheter device.

Articles

July 31, 2014 — Radiation therapy may offer a promising new noninvasive alternative treatment for the millions of Americans whose high blood pressure doesn’t...
Journal of Endovascular Therapy Hypertension Renal Denervation Therapy
Patients with hypertension after renal artery stenting who do not respond to drug treatment may have another option. 
Medtronic, SYMPLICITY, SYMPLICITY HTN-3 trial, renal denervation, ACC.14
A major disappointment earlier this year was the announcement by Medtronic that its renal denervation system failed to meet its primary endpoint for efficacy...
Medtronic, symplicity, renal denervation
Medtronic Inc. announced its U.S. pivotal trial for its Symplicity renal denervation system to treat resistant hypertension, the SYMPLICITY HTN-3 trial, failed...

Video Center

The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
5 weeks 12 hours ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
7 weeks 2 days ago
There were several new cardiovascular ultrasound technology advances highlighted at the American...
8 weeks 1 day ago
Join Ascendian Healthcare Consulting and GE Healthcare during a webinar Wednesday, July 16 to learn about the access, productivity, and revenue cycle...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
February is American Heart Month, the perfect time to evaluate the health of your cardiology IT system. 
Join us Feb. 25, 2-3 p.m. Eastern for a live...

Comparison Charts

Sorry there is no data available